1. [1] Ahima R, Osei S. Adipokines in obesity. Front Horm Res 2008; 36: 188-197. [DOI:10.1159/000115365] [PMID]

2. [2] Chilibeck PD, Pérez-López FR, Bodary PF, Kang ES, Jeon JY. Adipocytokines, metabolic syndrome, and exercise. Int J Endocrinol 2014; 2014. [DOI:10.1155/2014/597162] [PMID] [PMCID]

3. [3] Jensen M. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinal Metab 2008; 93: S57-S63. [DOI:10.1210/jc.2008-1585] [PMID] [PMCID]

4. [4] Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85. [DOI:10.1038/nri2921] [PMID] [PMCID]

5. [5] Feijoo-Bandin S, Rodriguez-Penas D, Garcia-Rua V, Mosquera-Leal A, Gonzalez-Juanatey J, Lago F. Adipokines at the cardiovascular system: role in health and disease. SM J Endocrinol Metab 2016; 2: 1009.

6. [6] Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009; 54: 1847-1856. [DOI:10.1007/s10620-008-0585-3] [PMID]

7. [7] Lee MK, Jekal Y, Im JA, Kim E, Lee SH, Park JH, et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 2010; 411: 381-385. [DOI:10.1016/j.cca.2009.12.003] [PMID]

8. [8] Phalitakul S, Okada M, Hara Y, Yamawaki H. Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacol Res 2011; 64: 493-500. [DOI:10.1016/j.phrs.2011.06.001] [PMID]

9. [9] Ploeger HE, Takken T, de Greef MH, Timmons BW. The effects of acute chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exerc Immunol Rev 2009; 15: 6-41.

10. [10] Yu Z, Ye X, Wang J, Qi Q, Franco OH, Rennie KL, et al. Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation 2009; 119: 2969-2977. [DOI:10.1161/CIRCULATIONAHA.108.833574] [PMID]

11. [11] Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 2005; 102: 10610-10615. [DOI:10.1073/pnas.0504703102] [PMID] [PMCID]

12. [12] Gao FF, Liu GL, Zheng RX, Jiang LH, Bao PL. Correlation between vaspin concentration and insulin sensitivity in the visceral adipose tissue of young obese rats. Zhongguo Dang Dai Er Ke Za Zhi 2013; 15: 71-74.

13. [13] Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006; 339: 430-436. [DOI:10.1016/j.bbrc.2005.11.039] [PMID]

14. [14] Kim SM, Cho GJ, Yannakoulia M, Hwang TG, Kim IH, Park EK, Mantzoros CS. Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 2011; 60: 1294-1299. [DOI:10.1016/j.metabol.2011.01.013] [PMID]

15. [15] Hill AM, Coates AM, Buckley JD, Ross R, Thielecke F, Howe PR. Can EGCG reduce abdominal fat in obese subjects?. J Am Coll Nutr 2007; 26: 396S-402S. [DOI:10.1080/07315724.2007.10719628] [PMID]

16. [16] Kang J, Rashti SL, Tranchina CP, Ratamess NA, Faigenbaum AD, Hoffman JR. Effect of preceding resistance exercise on metabolism during subsequent aerobic session. Eur J Appl Physiol 2009; 107: 43-50. [DOI:10.1007/s00421-009-1100-z] [PMID]

17. [17] Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377. [DOI:10.2337/db07-1045] [PMID]

18. [18] Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008; 57: 1501-1507. https://doi.org/10.2337/db07-0990 [DOI:10.2337/db08-0127]

19. [19] Safarzade A, Abbaspour-Seyedii A, Talebi-Garakani E, Fathi R, Saghebjoo M. Aerobic or resistance training improves anthropometric and metabolic parameters in overweight/obese women without any significant alteration in plasma vaspin levels. Sport Sci Health 2013; 9: 121-126. [DOI:10.1007/s11332-013-0157-6]

20. [20] Doaa M, Abdel-lateif S, Shereen, EI-Shaer. Association between changes in serum vaspin concentrations and changes of anthropometric variables in obese subjects after weight reduction. J Am Sci 2012; 8: 606-611.

21. [21] Cho JK, Han TK, Kang HS. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur J Appl Physiol 2010; 108: 347-353. [DOI:10.1007/s00421-009-1238-8] [PMID]

22. [22] Parrinello CM, Lutsey PL, Ballantyne CM, Folsom AR, Pankow JS, Selvin E. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. Am Heart J 2015; 170: 380-389. [DOI:10.1016/j.ahj.2015.04.017] [PMID] [PMCID]

23. [23] Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol 2013; 168: 5126-5134. [DOI:10.1016/j.ijcard.2013.07.113] [PMID]

24. [24] Kubota Y, Moriyama Y, Yamagishi K, Tanigawa T, Noda H, Yokota K, et al. Serum vitamin C concentration and hs-CRP level in middle-aged Japanese men and women. Atherosclerosis 2010; 208: 496-500. [DOI:10.1016/j.atherosclerosis.2009.07.052] [PMID]

25. [25] Fayh AP, Lopes AL, da Silva AM, Reischak-Oliveira A, Friedman R. Effects of 5% weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial. Eur J Nutr 2013; 52: 1443-1450. [DOI:10.1007/s00394-012-0450-1] [PMID]

26. [26] Eves ND, Plotnikoff RC. Resistance training and type 2 diabetes: Considerations for implementation at the population level. Diabetes Care 2006; 29: 1933-1941. [DOI:10.2337/dc05-1981] [PMID]

27. [27] Irvine C, Taylor NF. Progressive resistance exercise improves glycaemic control in people with type 2 diabetes mellitus: asystematic review. Aust J Physiother 2009; 55: 237-246. [DOI:10.1016/S0004-9514(09)70003-0]

28. [28] Chang HM, Lee HJ, Park HS, Kang JH, Kim KS, Song YS, Jang YJ. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) 2010; 18: 2105-2110. [DOI:10.1038/oby.2010.60] [PMID]

29. [29] Vink RG, Roumans NJ, Mariman EC, Van Baak MA. Dietary weight loss‐induced changes in RBP 4, FFA, and ACE predict weight regain in people with overweight and obesity. Physiol Rep 2017; 5: e13450. [DOI:10.14814/phy2.13450] [PMID] [PMCID]

30. [30] Oberbach A, Kirsch K, Lehmann S, Schlichting N, Fasshauer M, Zarse K, et al. Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes Facts 2010; 3: 328-331. [DOI:10.1159/000321637] [PMID] [PMCID]

31. [31] Brooks N, Layne JE, Gordon PL, Roubenoff R, Nelson ME, Castaneda-Sceppa C. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci 2006; 4: 19-27. [DOI:10.7150/ijms.4.19] [PMID] [PMCID]

32. [32] Kasapis C, Thompson P. The effects of physical activity on serum Creactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005; 45: 1563-1569. [DOI:10.1016/j.jacc.2004.12.077] [PMID]

33. [33] Mogharnasi M, TaheriChadorneshin H, Abbasi-Deloei N. Effect of exercise training type on plasma levels of vaspin, nesfatin-1, and high-sensitivity C-reactive protein in overweight and obese women. Obesity Med 2019; 13: 34-38. [DOI:10.1016/j.obmed.2018.12.006]

34. [34] Pestana MD, Netto EM, Pestana MC, Pestana VS, Schinoni MI. Pilates versus resistance exercise on the serum levels of hs-CRP, in the abdominal circumference and body mass index (BMI) in elderly individuals. Motricidade 2016; 12: 128-140. [DOI:10.6063/motricidade.6682]